2017 Form 10-K Financial Statement

#000143774918005217 Filed on March 22, 2018

View on sec.gov

Income Statement

Concept 2017 2016 Q4 2016
Revenue $40.75M $6.660M $24.61M
YoY Change 65.6% -22.83% -36.54%
Cost Of Revenue $33.60M $7.150M $24.82M
YoY Change 35.39% 8.01% -13.84%
Gross Profit $7.443M -$490.0K -$213.0K
YoY Change -3594.37% -124.5% -102.14%
Gross Profit Margin 18.26% -7.36% -0.87%
Selling, General & Admin $4.392M $890.0K $3.780M
YoY Change 16.2% -21.93% -11.28%
% of Gross Profit 59.01%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $5.833M $1.890M $6.865M
YoY Change -15.03% 22.73% 18.52%
% of Gross Profit 78.37%
Operating Expenses $40.83M $2.790M $35.62M
YoY Change 14.62% 3.72% -9.6%
Operating Profit -$3.757M -$3.280M -$11.01M
YoY Change -65.87% 375.36% 1675.0%
Interest Expense $2.261M -$340.0K $1.766M
YoY Change 28.03% 36.0% 58.59%
% of Operating Profit
Other Income/Expense, Net -$2.724M $30.00K -$1.480M
YoY Change 84.05% 200.0% 39.75%
Pretax Income -$6.481M -$3.610M -$12.49M
YoY Change -48.11% 268.37% 643.71%
Income Tax -$561.0K -$880.0K -$3.938M
% Of Pretax Income
Net Earnings -$6.893M -$2.740M -$8.551M
YoY Change -19.39% 207.87% 578.1%
Net Earnings / Revenue -16.91% -41.14% -34.75%
Basic Earnings Per Share -$0.22
Diluted Earnings Per Share -$2.024M -$65.99K -$0.22
COMMON SHARES
Basic Shares Outstanding 51.07M 38.98M
Diluted Shares Outstanding 38.98M

Balance Sheet

Concept 2017 2016 Q4 2016
SHORT-TERM ASSETS
Cash & Short-Term Investments $391.0K $620.0K $620.8K
YoY Change -37.01% -22.5% -22.86%
Cash & Equivalents $391.0K $621.0K $620.8K
Short-Term Investments
Other Short-Term Assets $1.493M $970.0K $970.8K
YoY Change 53.79% -19.83% -19.97%
Inventory $552.0K $407.0K $407.4K
Prepaid Expenses
Receivables $11.16M $4.814M $4.814M
Other Receivables $57.00K $230.0K $223.8K
Total Short-Term Assets $13.65M $7.037M $7.037M
YoY Change 94.02% -26.59% -26.59%
LONG-TERM ASSETS
Property, Plant & Equipment $28.31M $34.62M $34.62M
YoY Change -18.22% -5.14% -5.14%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.927M $715.0K $715.0K
YoY Change 169.52% -18.2% -18.21%
Total Long-Term Assets $30.60M $35.33M $35.33M
YoY Change -13.4% -5.45% -5.45%
TOTAL ASSETS
Total Short-Term Assets $13.65M $7.037M $7.037M
Total Long-Term Assets $30.60M $35.33M $35.33M
Total Assets $44.25M $42.37M $42.37M
YoY Change 4.44% -9.76% -9.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.276M $3.680M $3.683M
YoY Change 43.27% 21.05% 21.14%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $182.0K $318.0K $318.5K
YoY Change -42.86% 1.19% 1.35%
Total Short-Term Liabilities $5.647M $4.001M $4.001M
YoY Change 41.14% 19.29% 19.29%
LONG-TERM LIABILITIES
Long-Term Debt $29.55M $304.0K $23.48M
YoY Change 25.81% -48.52% 10.27%
Other Long-Term Liabilities $831.0K
YoY Change
Total Long-Term Liabilities $30.38M $23.95M $23.48M
YoY Change 29.35% -6.84% 10.27%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.647M $4.001M $4.001M
Total Long-Term Liabilities $30.38M $23.95M $23.48M
Total Liabilities $36.03M $27.96M $27.95M
YoY Change 28.87% -3.83% -3.83%
SHAREHOLDERS EQUITY
Retained Earnings -$4.708M
YoY Change -222.49%
Common Stock $255.0K
YoY Change 33.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares $103.6K
Shareholders Equity $8.225M $14.42M $14.42M
YoY Change
Total Liabilities & Shareholders Equity $44.25M $42.37M $42.37M
YoY Change 4.44% -9.76% -9.76%

Cashflow Statement

Concept 2017 2016 Q4 2016
OPERATING ACTIVITIES
Net Income -$6.893M -$2.740M -$8.551M
YoY Change -19.39% 207.87% 578.1%
Depreciation, Depletion And Amortization $5.833M $1.890M $6.865M
YoY Change -15.03% 22.73% 18.52%
Cash From Operating Activities -$3.989M -$3.150M -$1.997M
YoY Change 99.75% 331.51% -116.44%
INVESTING ACTIVITIES
Capital Expenditures $1.677M -$370.0K $5.165M
YoY Change -67.53% -61.46% 13.93%
Acquisitions
YoY Change
Other Investing Activities $373.0K $100.0K $419.3K
YoY Change -11.04% 400.0% 1443.21%
Cash From Investing Activities -$1.304M -$270.0K -$4.746M
YoY Change -72.52% -71.28% 5.32%
FINANCING ACTIVITIES
Cash Dividend Paid $0.00 $0.00
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $5.175M
YoY Change -100.0%
Debt Paid & Issued, Net $189.0K $282.0K
YoY Change -32.98% 18.63%
Cash From Financing Activities 5.063M 3.250M 6.559M
YoY Change -22.81% 88.95% -184.23%
NET CHANGE
Cash From Operating Activities -3.989M -3.150M -1.997M
Cash From Investing Activities -1.304M -270.0K -4.746M
Cash From Financing Activities 5.063M 3.250M 6.559M
Net Change In Cash -230.0K -170.0K -184.0K
YoY Change 25.0% -440.0% 23.22%
FREE CASH FLOW
Cash From Operating Activities -$3.989M -$3.150M -$1.997M
Capital Expenditures $1.677M -$370.0K $5.165M
Free Cash Flow -$5.666M -$2.780M -$7.162M
YoY Change -20.89% -1308.7% -194.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4814000
CY2017Q4 ensv Aggregate Intrinsic Value Of Warrants Exercised
AggregateIntrinsicValueOfWarrantsExercised
19000
CY2017Q4 ensv Amendment Fee
AmendmentFee
20000
CY2017 ensv Amortization Of Debt And Warrant Issuance Costs
AmortizationOfDebtAndWarrantIssuanceCosts
484000
CY2016Q4 ensv Share Based Compensation Arrangement By Share Based Payment Award Options And Warrants Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndWarrantsOutstandingNumber
4391169
CY2016 ensv Amortization Of Debt And Warrant Issuance Costs
AmortizationOfDebtAndWarrantIssuanceCosts
153000
CY2017Q4 ensv Available Liquidity
AvailableLiquidity
2400000
CY2016Q4 ensv Available Liquidity
AvailableLiquidity
5200000
CY2016 ensv Severance And Transition Costs
SeveranceAndTransitionCosts
CY2017 ensv Change In Deferred Tax Expense Benefit
ChangeInDeferredTaxExpenseBenefit
-331000
CY2016 ensv Change In Deferred Tax Expense Benefit
ChangeInDeferredTaxExpenseBenefit
-3938000
CY2017Q4 ensv Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
4026000
CY2016Q4 ensv Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
6871000
CY2017Q4 ensv Identifiable Assets
IdentifiableAssets
42878000
CY2016Q4 ensv Identifiable Assets
IdentifiableAssets
40296000
CY2017Q4 ensv Increase Decrease Of Deferred Tax Assets As A Result Of Tax Cuts And Jobs Act
IncreaseDecreaseOfDeferredTaxAssetsAsAResultOfTaxCutsAndJobsAct
-585000
CY2017Q4 ensv Line Of Credit Facility Covenant Compliance Liquidity At Period End
LineOfCreditFacilityCovenantComplianceLiquidityAtPeriodEnd
2400000
CY2017 ensv Line Of Credit Repayed
LineOfCreditRepayed
1500000
CY2016 ensv Line Of Credit Repayed
LineOfCreditRepayed
CY2017Q4 ensv Long Term Debt Excluding Subordinated Debt Noncurrent
LongTermDebtExcludingSubordinatedDebtNoncurrent
252000
CY2016Q4 ensv Long Term Debt Excluding Subordinated Debt Noncurrent
LongTermDebtExcludingSubordinatedDebtNoncurrent
304000
CY2017 ensv Payments On Workers Compensation Claims
PaymentsOnWorkersCompensationClaims
612000
CY2017 ensv Payments To Acquire Property Plant And Equipment Excluding Acquisitions
PaymentsToAcquirePropertyPlantAndEquipmentExcludingAcquisitions
1766000
CY2016 ensv Payments To Acquire Property Plant And Equipment Excluding Acquisitions
PaymentsToAcquirePropertyPlantAndEquipmentExcludingAcquisitions
1017000
CY2015Q2 ensv Selfinsured Amount Per Individual Claim
SelfinsuredAmountPerIndividualClaim
50000
CY2017 ensv Severance And Transition Costs
SeveranceAndTransitionCosts
784000
CY2017Q4 ensv Share Based Compensation Arrangement By Share Based Payment Award Options And Warrants Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndWarrantsOutstandingAggregateIntrinsicValue
1500000
CY2017Q4 ensv Share Based Compensation Arrangement By Share Based Payment Award Options And Warrants Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndWarrantsOutstandingNumber
6457335
CY2017 ensv Stock Issued From Exercise Of Warrants
StockIssuedFromExerciseOfWarrants
112500
CY2017Q4 ensv Warrant Liabilities Noncurrent
WarrantLiabilitiesNoncurrent
831000
CY2016Q4 ensv Warrant Liabilities Noncurrent
WarrantLiabilitiesNoncurrent
CY2017Q4 ensv Workers Compensation Accumulated Payments On Claims
WorkersCompensationAccumulatedPaymentsOnClaims
1600000
CY2017 ensv Workers Compensation Estimated Accruals
WorkersCompensationEstimatedAccruals
161000
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5465000
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3683000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11761000
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2017 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
37979000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
32227000
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
19571000
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18868000
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
70000
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
34000
CY2017 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
448000
CY2016 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
153000
CY2016 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2017Q4 us-gaap Assets
Assets
44250000
CY2016Q4 us-gaap Assets
Assets
42370000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
13653000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
7037000
CY2017Q4 us-gaap Cash
Cash
391000
CY2016Q4 us-gaap Cash
Cash
621000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
621000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
805000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
391000
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-230000
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-184000
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.005
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.005
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51197989
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51171260
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51094389
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51067660
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
255000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
255000
CY2017 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-style: italic;">Concentrations</div></div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div>&nbsp;customer&nbsp;comprised more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of the Company&#x2019;s accounts receivable balance; at approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13%.</div> Revenues from this customer&nbsp;represented approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8%</div>&nbsp;of total revenues&nbsp;for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017.&nbsp;</div>In addition, there was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> other customer which represented more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of total revenue for the year at approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13%</div> for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017.&nbsp;</div>As of<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> customers each comprised more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of the Company&#x2019;s accounts receivable balance; at approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14%,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11%,</div> respectively. Revenues from these <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> customers represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14%,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12%</div> of total revenues, respectively, for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2017 us-gaap Cost Of Revenue
CostOfRevenue
33604000
CY2016 us-gaap Cost Of Revenue
CostOfRevenue
24821000
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-499000
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3577000
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-561000
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3938000
CY2017Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
4026000
CY2016Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
6871000
CY2017Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
96000
CY2016Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
92000
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-62000
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-361000
CY2017Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
1000
CY2016Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
1000
CY2017Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
41000
CY2016Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
100000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
5526000
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
6792000
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
57000
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4026000
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
6402000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
5116000
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
5949000
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
113000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
164000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
390000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
204000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
239000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1500000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
390000
CY2016Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
469000
CY2017Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
CY2016Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
469000
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6488000
CY2016 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6865000
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6488000
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6865000
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2017Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
55400
CY2017 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y153D
CY2017 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
524000
CY2016 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
CY2017 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-18000
CY2016 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
242000
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5243000
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3780000
CY2017 us-gaap Gross Profit
GrossProfit
7148000
CY2016 us-gaap Gross Profit
GrossProfit
-213000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7454000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12489000
CY2017 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2016 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-561000
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3938000
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1193000
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
389000
CY2017 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
585000
CY2016 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2533000
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-4229000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
408000
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
262000
CY2017 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-12000
CY2016 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
13000
CY2017 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-202000
CY2016 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-373000
CY2017 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-222000
CY2016 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
14000
CY2017Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
57000
CY2016Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
224000
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2425000
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
642000
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7069000
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2066000
CY2017 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-111000
CY2016 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
1000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
168000
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
99000
CY2017 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
403000
CY2016 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-26000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-84000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-261000
CY2017 us-gaap Interest Expense
InterestExpense
2261000
CY2016 us-gaap Interest Expense
InterestExpense
1766000
CY2017 us-gaap Interest Paid Net
InterestPaidNet
674000
CY2016 us-gaap Interest Paid Net
InterestPaidNet
67000
CY2017Q4 us-gaap Inventory Net
InventoryNet
576000
CY2016Q4 us-gaap Inventory Net
InventoryNet
407000
CY2017 us-gaap Inventory Write Down
InventoryWriteDown
0
CY2016 us-gaap Inventory Write Down
InventoryWriteDown
0
CY2017 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
CY2016 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
2000
CY2017 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
808000
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
789000
CY2017 us-gaap Legal Fees
LegalFees
129000
CY2016 us-gaap Legal Fees
LegalFees
151000
CY2017Q4 us-gaap Liabilities
Liabilities
36025000
CY2016Q4 us-gaap Liabilities
Liabilities
27955000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44250000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
42370000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5647000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4001000
CY2017Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
30378000
CY2016Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
23954000
CY2017 us-gaap Line Of Credit Assumed1
LineOfCreditAssumed1
1124000
CY2016 us-gaap Line Of Credit Assumed1
LineOfCreditAssumed1
1543000
CY2017Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
27066000
CY2016Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
23181000
CY2017 us-gaap Loans Assumed1
LoansAssumed1
1500000
CY2016 us-gaap Loans Assumed1
LoansAssumed1
CY2017Q4 us-gaap Long Term Debt
LongTermDebt
2663000
CY2016Q4 us-gaap Long Term Debt
LongTermDebt
622000
CY2017Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
182000
CY2016Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
318000
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
22000
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
182000
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
2290000
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
59000
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
56000
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
54000
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2481000
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
304000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5063000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6559000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1304000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4746000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3989000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1997000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-6893000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-8551000
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2742000
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1480000
CY2017 us-gaap Operating Expenses
OperatingExpenses
45464000
CY2016 us-gaap Operating Expenses
OperatingExpenses
35617000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-4712000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-11009000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2419000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
654000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
181000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
377000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
574000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
633000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
CY2017Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
20000000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1123000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
715000
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-463000
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
44000
CY2017 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
1000
CY2016 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
758000
CY2017 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
59000
CY2016 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
50000
CY2017 us-gaap Payments Of Dividends
PaymentsOfDividends
0
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1766000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5165000
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.005
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.005
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
868000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
971000
CY2017 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; text-decoration: underline;">Reclassifications&nbsp;</div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">Certain prior-period amounts have been reclassified for comparative purposes to conform to the fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>&nbsp;presentation. These reclassifications have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> effect on the Company&#x2019;s consolidated statement of operations.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2017 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
183000
CY2016 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
280000
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5175000
CY2017 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1000000
CY2016 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
CY2017 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
4312000
CY2016 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
2474000
CY2017 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
279000
CY2016 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
139000
CY2017 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
26729
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
67396000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
66845000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29417000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34618000
CY2017 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
37000
CY2016 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
157000
CY2017 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
189000
CY2016 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
282000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11601000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4708000
CY2017 us-gaap Revenues
Revenues
40752000
CY2016 us-gaap Revenues
Revenues
24608000
CY2017Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
102000
CY2016Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
23000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
704000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
662000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2282834
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.02
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2799000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2368334
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2971600
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3525000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.19
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.28
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
63000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
46000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1007000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3485168
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4211168
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4814434
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.31
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.09
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.71
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
317000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2282834
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.02
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.96
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.90
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.78
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.32
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
317000
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y281D
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1323669
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1659834
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
2531599
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
1254000
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
96668
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0.56
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0.55
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.22
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.58
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.24
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y193D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y310D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y167D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P2Y281D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.49
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.43
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
1934835
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
2003167
CY2016 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
2000
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4416000
CY2017 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
703000
CY2016 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
662000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
17886000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
14415000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
8225000
CY2017Q4 us-gaap Subordinated Long Term Debt
SubordinatedLongTermDebt
2229000
CY2016Q4 us-gaap Subordinated Long Term Debt
SubordinatedLongTermDebt
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
103600
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
103600
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; text-decoration: underline;">Management Estimates</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The preparation of the Company<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the realization of accounts receivable, evaluation of impairment of long-lived assets, stock-based compensation expense, income tax provision, the valuation of deferred taxes, and the valuation of warrants and the Company&#x2019;s interest rate swap. Actual results could differ from those estimates.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
51070
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39117

Files In Submission

Name View Source Status
0001437749-18-005217-index-headers.html Edgar Link pending
0001437749-18-005217-index.html Edgar Link pending
0001437749-18-005217.txt Edgar Link pending
0001437749-18-005217-xbrl.zip Edgar Link pending
a1.jpg Edgar Link pending
a3.jpg Edgar Link pending
ensv-20171231.xml Edgar Link completed
ensv-20171231.xsd Edgar Link pending
ensv-20171231_cal.xml Edgar Link unprocessable
ensv-20171231_def.xml Edgar Link unprocessable
ensv-20171231_lab.xml Edgar Link unprocessable
ensv-20171231_pre.xml Edgar Link unprocessable
ensv20171231_10k.htm Edgar Link pending
ex_102684.htm Edgar Link pending
ex_102686.htm Edgar Link pending
ex_102687.htm Edgar Link pending
ex_102688.htm Edgar Link pending
ex_102689.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending